Antibody Effector Functions and Opsonization

Binding an antigen is only the first step of antibody action; what happens next depends on the antibody's Fc region, which links the bound target to effector systems. Through opsonisation, complement activation, and engagement of Fc receptors, antibodies mark pathogens for phagocytosis, trigger killing, and neutralise toxins, turning specific recognition into an immune outcome.

Definition

Antibody effector functions are the responses, mediated by the Fc region after antigen binding, that recruit immune mechanisms against the target; opsonisation is the coating of a pathogen with antibody (and complement) that promotes its recognition and ingestion by phagocytes.

Scope

The topic covers neutralisation, opsonisation and phagocytosis, complement activation by the classical pathway, antibody-dependent cellular cytotoxicity, and how Fc receptors and Fc glycosylation tune these activities across antibody classes and IgG subclasses. It is presented as effector immunology for reference rather than as clinical instruction.

Core questions

• How does antigen binding by the Fab region get translated into an effector response by the Fc region?
• What distinguishes neutralisation, opsonisation, complement activation, and cellular cytotoxicity?
• How do antibody class and Fc receptors determine which effector functions occur?
• How does Fc glycosylation modulate effector activity?

Key concepts

• Neutralisation
• Opsonisation
• Fc receptors (FcγR, FcεR, FcαR)
• Classical complement pathway
• C3b and complement-mediated opsonisation
• Antibody-dependent cellular cytotoxicity
• Phagocytosis
• Fc glycosylation

Mechanisms

Once an antibody binds antigen through its Fab arms, its Fc region determines the downstream effect. In neutralisation the antibody simply blocks a pathogen or toxin from interacting with host cells. In opsonisation the antibody coats the target so that phagocytes bearing Fc receptors recognise and ingest it, a process amplified when complement deposits C3b on the surface. Antigen-bound IgG and IgM can initiate the classical complement pathway by binding C1q, leading to opsonisation, inflammation, and membrane attack. In antibody-dependent cellular cytotoxicity, antibody-coated cells are killed by Fc-receptor-bearing effectors such as natural killer cells. Which functions are available depends on the antibody class and IgG subclass and on the array of activating and inhibitory Fc receptors engaged, while the conserved N-linked glycan on the Fc region modulates the strength of these interactions.

Clinical relevance

Effector mechanisms explain how vaccines and natural infection confer protection, how some pathogens evade antibody, and how therapeutic antibodies are engineered for or against particular Fc activities. The topic describes these mechanisms and does not provide diagnostic or treatment recommendations.

History

The concept of opsonisation dates to early twentieth-century work on serum factors that prepare microbes for phagocytosis. The molecular dissection of Fc receptors, the complement pathways, and the influence of Fc glycosylation over later decades clarified how a single bound antibody can trigger several distinct effector outcomes, and these insights now guide antibody engineering.

Key figures

• Jeffrey Ravetch
• Falk Nimmerjahn
• John Lambris
• Raymond Dwek

Seminal works

• nimmerjahn-ravetch-2008
• ricklin-2010

Frequently asked questions

What does opsonisation actually do?

It coats a pathogen with antibody, and often complement, so that phagocytes carrying Fc and complement receptors recognise and engulf it more efficiently than they could the uncoated microbe.

Why do different antibody classes have different effector functions?

The effector function is determined by the Fc region of the heavy-chain constant region, which differs between classes and subclasses and so binds different Fc receptors and complement components.